|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
| Trial Status | Open |
| Dates | Date of activation: 18/01/2010 |
| Data management at EORTC | Mailbox |
| Phase | 3 |
| Randomized trial | Yes |
| Type | Adjuvant |
| Targeted Sample size | EORTC Groups: 400 - All Groups: 610 |
| Number of steps | 1 |
| Drug | |
| Study Staff | Helen Westenberg (Study Coordinator) - Arnhem 'S Radiotherapeutisch Instituut, Arnhem Laurence Collette (Statistician) - EORTC, Brussels Livia Giurgea (Data Manager) - EORTC, Brussels Cecilia Liberatoscioli (Coordinating Physician) - EORTC, Brussels Nadège Gosselin (Project Manager) - EORTC, Brussels, nadege.gosselin( at )eortc.be, +32 2 7741690 |
| Type of cancer | Breast |
| Participating Groups | Trans-Tasman Radiation Oncology Group Inc(Coordinating Group) EORTC Breast Cancer Group EORTC Radiation Oncology Group Borstkanker Onderzoeksgroup Nederland |
| Currently authorized centers | |
| Protocol summary | Link provided by NCI PDQ |
| Protocol documents in PDF (requires password) | 22085.pdf |